Australis Capital (OTCPK:AUSA.F) - Stock Price, News & Analysis

AUSA.F Stock Overview

Australis Capital Inc. opera como empresa de cannabis.

AUSA.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Risk Analysis

No tiene una capitalización bursátil significativa ($9M)

Las acciones son altamente ilíquidas

Los últimos informes financieros tienen más de un año

Australis Capital Inc. Competitors

Avenue Therapeutics

NasdaqCM:ATXI

US$6.6m

Hoth Therapeutics

NasdaqCM:HOTH

US$6.2m

Enveric Biosciences

NasdaqCM:ENVB

US$6.8m

Polydex Pharmaceuticals

OTCPK:POLX.F

US$6.8m

Price History & Performance

Summary of all time highs, changes and price drops for Australis Capital
Historical stock prices
Current Share Price	CA$0.0001
52 Week High	CA$0.05
52 Week Low	CA$0.000001
Beta	0
1 Month Change	9,900.00%
3 Month Change	9,900.00%
1 Year Change	-99.03%
3 Year Change	-99.97%
5 Year Change	-99.99%
Change since IPO	-100.00%

Recent updates

Shareholder Returns

	AUSA.F	US Pharmaceuticals	US Market
7D	9,900.0%	-0.6%	-0.8%
1Y	-99.0%	16.6%	25.9%

Rentabilidad frente al sector: AUSA.F obtuvo unos resultados inferiores a los del sector US Pharmaceuticals , que el año pasado arrojó un rendimiento del 6.6%.

Rentabilidad vs. Mercado: AUSA.F obtuvo unos resultados inferiores a los del mercado US, que fue del 21% el año pasado.

Price Volatility

Is AUSA.F's price volatile compared to industry and market?
AUSA.F volatility
AUSA.F Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.5%
Market Average Movement	6.0%
10% most volatile stocks in US Market	16.7%
10% least volatile stocks in US Market	3.0%

Precio estable de las acciones: AUSA.Fha sido volátil en los últimos 3 meses.

Volatilidad a lo largo del tiempo: Datos insuficientes para determinar el cambio de volatilidad de AUSA.F en el último año.

About the Company

Founded	Employees	CEO	Website
2015	n/a	Terry Booth	https://www.ausacap.com

Australis Capital Inc. opera como empresa de cannabis. Lleva a cabo proyectos relacionados y no relacionados con el cannabis y la horticultura en Estados Unidos, Canadá, Dinamarca, Finlandia, Islandia, Alemania, Países Bajos, Bahrein, Kuwait, Sudeste Asiático y Australia, así como en otras jurisdicciones. La empresa tiene su sede en Las Vegas, Nevada.

Australis Capital Inc. Fundamentals Summary

How do Australis Capital's earnings and revenue compare to its market cap?
AUSA.F fundamental statistics
Market cap	US$6.44m
Earnings (TTM)	-US$50.09m
Revenue (TTM)	US$9.47m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is AUSA.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AUSA.F income statement (TTM)
Revenue	CA$9.47m
Cost of Revenue	CA$3.61m
Gross Profit	CA$5.87m
Other Expenses	CA$55.96m
Earnings	-CA$50.09m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did AUSA.F perform over the long term?

See historical performance and comparison

AUSA.F Stock Overview

Rewards

Risk Analysis

Australis Capital Inc. Competitors

NasdaqCM:ATXI

US$6.6m

NasdaqCM:HOTH

US$6.2m

NasdaqCM:ENVB

US$6.8m

OTCPK:POLX.F

US$6.8m

Price History & Performance

Recent News & Updates

Australis Capital Inc. Announces Executive Changes

Australis Capital Inc Completes Final New Jersey License Application Step

Australis Capital Inc. Announces Board Changes

Australis Capital Inc. Appoints Jill Swainson as Member of Board of Directors

Australis Capital Inc. Announces Mr. Natural, an AUDACIOUS Brand, Launched Its First Product in Nevada: Full Spectrum Hash RSO

Australis Capital Inc. to Report Q3, 2022 Results on Mar 01, 2022

Recent updates

Australis Capital Inc. Announces Executive Changes

Australis Capital Inc Completes Final New Jersey License Application Step

Australis Capital Inc. Announces Board Changes

Australis Capital Inc. Appoints Jill Swainson as Member of Board of Directors

Australis Capital Inc. Announces Mr. Natural, an AUDACIOUS Brand, Launched Its First Product in Nevada: Full Spectrum Hash RSO

Australis Capital Inc. to Report Q3, 2022 Results on Mar 01, 2022

Australis Capital Inc. (CNSX:AUSA) completed the acquisition of Gary Maverick Inc. for $0.5 million.

Australis Capital Inc. announced that it expects to receive CAD 20 million in funding

Australis Capital Inc. announced that it expects to receive CAD 15 million in funding

Toro Pacific Management Inc. acquired 5.8% stake in Body and Mind Inc. (OTCPK:BMMJ) from Australis Capital Inc. (CNSX:AUSA) for CAD 1.8 million.

Australis Capital Inc. (CNSX:AUSA) agreed to acquire Gary Maverick Inc.

Australis Capital Inc. Intends to Launch Additional Products Lines Under the New Name

Australis Capital Inc. (CNSX:AUSA) completed the acquisition of 51% in 2750176 Ontario Inc. from shareholders.

Australis Capital Inc. Announces Management Changes

Australis Capital Inc. and 3 Rivers Biotech Inc. Enter into Tissue Culture Joint Venture

Australis Capital Inc. and Cann Group Limited Sign Agreement

Australis Capital Inc. (CNSX:AUSA) entered into a non-binding term sheet to acquire 51% in 2750176 Ontario Inc. from shareholders for CAD 25.9 million.

Australis Capital Inc. (CNSX:AUSA) signed a non-binding term sheet to acquire Green Therapeutics LLC for CAD 10 million.

Australis Capital Inc. Appoints Jon Paul as its New CFO

Australis Capital Inc. Announces Management Changes

Australis Capital Inc. Announces Chief Executive Officer Changes

Australis Capital Inc. Appoints Sameer Kumar as Independent Member of its Board of Directors

Australis Capital Inc. (CNSX:AUSA) completed the acquisition of Paytron, LLC.

Shareholder Returns

Price Volatility

About the Company

Australis Capital Inc. Fundamentals Summary

0.0x

0.0x

Earnings & Revenue